Discussion & Analysis Q3/2021 Operating Highlights in Q3/2021 Q3/20 Q3/21 Change +/(-) 9M/20 9M/21 Change +/(-) (THB million) %YoY %YoY Operating Revenue 198 115 (42%) 561 431 (23%) Gross Profit 124 60 (52
%. Net profit For the year ended 31 December 2018, the Company and its subsidiaries had net profits of THB 227.68 million, an increase of THB 40.01 million or 21.32% from the year of 2017. Although the
11.86% Finance cost 19.72 18.41 (1.31) (6.64%) Income tax expenses 17.98 22.21 4.23 23.53% Net profit 70.57 80.50 9.93 14.07% Net profit ratio (ROS) 20.41% 18.98% Earnings per share (Baht) 0.13 0.15 0.02
improve the sales and ownership transfer volume of the Company. In 2019, the net profit of the Company and subsidiary companies has increased from that in 2018 because of better operational efficiency. The
higher than estimated budget. (4) Gross profit The Company and its subsidiaries’ gross profit was of Baht 0.31 million, decreased by Baht 31.32 million or more than 99.03% from the period of previous year
the name of shareholders according to the Securities and Exchange Act section 225 will be on September 5, 2018. The interim dividend will be paid on September 18, 2018 from net profit that still enjoys
acceptable risk level, which has resulted in its satisfactory financial status, liquidity, and profit growth. This has helped the Company earn trust and confidence from banks and financial institutions in
% Finance cost 18.41 36.80 18.39 99.89% Income tax expenses 22.21 28.27 6.06 27.29% Net profit 80.50 95.26 14.76 18.34% Net profit ratio (ROS) 18.98% 20.67% Earnings per share (Baht) 0.13 0.16 0.03 23.08
treatment systems 34.69 81.63 (57.50) Selling expenses 58.75 43.36 35.49 Administrative expenses - WIIK 55.63 53.03 4.90 - WW 41.87 20.35 105.75 Finance cost 42.25 34.20 23.54 Profit before income tax income
1,462.48 million. This transaction is categorized to be the acquisition of assets according to the Notification of the Capital Market Supervisory Board No. Tor. Jor. 20/2551 Re: Rules on Entering into